Kidswell Bio (TSE:4584) 1-Year Sharpe Ratio: -1.06 (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4584 Kidswell Bio Corp TSE:4584
45 GF Score
Price 円170.00
GF Value 円238.81
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Kidswell Bio 1-Year Sharpe Ratio?

Kidswell Bio TSE:4584 +1.80% 45 1-Year Sharpe Ratio is -1.06 as of Aug. 21, 2026. GuruFocus rates TSE:4584 with a GF Score™ of 45/100 and a GF Value™ of 円238.81 (Modestly Undervalued). The stock has 6 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-21), Kidswell Bio's 1-Year Sharpe Ratio is -1.06.

Kidswell Bio  (TSE:4584) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Kidswell Bio 1-Year Sharpe Ratio Related Terms

TSE:4584 vs VRTX, REGN, RVMD: 1-Year Sharpe Ratio Comparison

For the Biotechnology subindustry, Kidswell Bio's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kidswell Bio 1-Year Sharpe Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kidswell Bio's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Kidswell Bio's 1-Year Sharpe Ratio falls into.


TSE:4584
45GF Score
Kidswell Bio Corp TSE:4584
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kidswell Bio 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -1.06 mean?
Kidswell Bio (TSE:4584) has a 1-Year Sharpe Ratio of -1.06 as of Aug. 21, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Kidswell Bio and its competitors.
Is Kidswell Bio's 1-Year Sharpe Ratio too high?
Kidswell Bio's current 1-Year Sharpe Ratio is -1.06. Overall, Kidswell Bio has a GF Score™ of 45/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kidswell Bio's 1-Year Sharpe Ratio compare to VRTX and REGN?
Kidswell Bio's 1-Year Sharpe Ratio of -1.06 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Biotechnology company?
A good 1-Year Sharpe Ratio depends on the Biotechnology industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Kidswell Bio and its competitors. Kidswell Bio's current 1-Year Sharpe Ratio is -1.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kidswell Bio stock overvalued right now?
Based on GuruFocus' analysis, Kidswell Bio (TSE:4584) is currently considered Modestly Undervalued. The stock's GF Value™ is 円238.81, compared to a current price of 円170.00 — trading 28.8% below its estimated fair value. The current 1-Year Sharpe Ratio is -1.06. Kidswell Bio's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Kidswell Bio (TSE:4584), the current 1-Year Sharpe Ratio is -1.06 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kidswell Bio (TSE:4584) Overvalued in 2026?

Based on GuruFocus' analysis, Kidswell Bio stock appears to be undervalued. The current stock price of 円170.00 is trading 28.8% below its estimated GF Value™ of 円238.81. GuruFocus considers Kidswell Bio to be Modestly Undervalued.

Key valuation signals for TSE:4584:

  • 1-Year Sharpe Ratio: -1.06
  • GF Value™: 円238.81 vs. price of 円170.00 (28.8% below fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the TSE:4584 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kidswell Bio Business Description

Address 1-2-12, Shinkawa, Kanayama Building, 3rd Floor, Chuo-ku, Tokyo, JPN, 104-0033
Kidswell Bio Corp is a biopharmaceutical company engaged in the discovery and development of drugs.
45GF Score

Get the complete analysis for TSE:4584

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円170.00
Price
円238.81
GF Value